The Effects of Topiroxostat, a Selective Xanthine Oxidoreductase Inhibitor, on Arterial Stiffness in Hyperuricemic Patients with Liver Dysfunction: A Sub-Analysis of the BEYOND-UA Study

Background: The effects of uric acid (UA)-lowering therapy with xanthine oxidoreductase (XOR) inhibitors on the development of cardiovascular diseases remain controversial. Based on recent findings that plasma XOR activity increased in liver disease conditions, we conducted a sub-analysis of the BEY...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujishima, Yuya, Nishizawa, Hitoshi, Kawachi, Yusuke, Nakamura, Takashi, Akari, Seigo, Ono, Yoshiyuki, Fukuda, Shiro, Kita, Shunbun, Maeda, Norikazu, Hoshide, Satoshi, Shimomura, Iichiro, Kario, Kazuomi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045538/
https://www.ncbi.nlm.nih.gov/pubmed/36979653
http://dx.doi.org/10.3390/biomedicines11030674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045538/
https://www.ncbi.nlm.nih.gov/pubmed/36979653
http://dx.doi.org/10.3390/biomedicines11030674

Ejemplares similares